Skip to main content
Premium Trial:

Request an Annual Quote

Dx Focus Sep 9, 2010: Clinical and Regulatory PCR and Nucleic Acid Testing News

Premium

Myconostica said this week that its MycAssay Aspergillus test has received the CE mark for detecting Aspergillus spp. DNA in serum.

MycAssay Aspergillus is a molecular diagnostic assay designed to be used by laboratory professionals, and the results of the test aid physicians in diagnosing patients suspected of having an infection caused by Aspergillus, according to Manchester, UK-based Myconostica.

MycAssay Aspergillus previously received the CE mark for respiratory samples, meaning that the test is now CE marked for all major sample types. There are a number of high-risk patient groups for whom it is difficult to obtain respiratory samples, Myconostica said.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.